|
ID |
Name |
Source |
pValue |
FDR B&H |
FDR B&Y |
Bonferroni |
Genes from Input
|
Genes in Annotation
|
1
|
liver
|
liver
|
Human Protein Atlas
|
3.009E-7
|
8.972E-5
|
6.395E-4
|
2.103E-4
|
5
|
419
|
2
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Liver
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Liver
|
Tabula Muris Consortium
|
3.075E-7
|
8.972E-5
|
6.395E-4
|
2.150E-4
|
4
|
156
|
3
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Liver/hepatocyte
|
Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Liver/hepatocyte
|
Tabula Muris Consortium
|
3.851E-7
|
8.972E-5
|
6.395E-4
|
2.692E-4
|
4
|
165
|
4
|
ratio EB-blastocyst vs EB-cbCD34 500 K1
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-derived-from CD34-iPSC top-relative-expression-ranked 500 k-means-cluster#1
|
PCBC
|
7.210E-7
|
1.260E-4
|
8.980E-4
|
5.040E-4
|
4
|
193
|
5
|
Facebase ST1 Univ 250
|
UniversalReference WholeMouseP1 top-relative-expression-ranked 250
|
FaceBase_ST1
|
9.353E-7
|
1.308E-4
|
9.320E-4
|
6.538E-4
|
4
|
206
|
6
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 100 k2
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 k-means-cluster#2 top-relative-expression-ranked 100
|
Gudmap Mouse MOE430.2
|
1.189E-6
|
1.386E-4
|
9.877E-4
|
8.314E-4
|
3
|
54
|
7
|
BM Top 100 - liver
|
BM Top 100 - liver
|
Body Map
|
3.919E-6
|
3.073E-4
|
2.190E-3
|
2.739E-3
|
3
|
80
|
8
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 100
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 top-relative-expression-ranked 100
|
Gudmap Mouse MOE430.2
|
3.919E-6
|
3.073E-4
|
2.190E-3
|
2.739E-3
|
3
|
80
|
9
|
ratio EB-blastocyst vs EB-cbCD34 1000 K2
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-derived-from CD34-iPSC top-relative-expression-ranked 1000 k-means-cluster#2
|
PCBC
|
3.957E-6
|
3.073E-4
|
2.190E-3
|
2.766E-3
|
4
|
296
|
10
|
Facebase ST1 Univ 100
|
UniversalReference WholeMouseP1 top-relative-expression-ranked 100
|
FaceBase_ST1
|
4.541E-6
|
3.174E-4
|
2.262E-3
|
3.174E-3
|
3
|
84
|
11
|
PCBC EB blastocyst 100
|
Progenitor-Cell-Biology-Consortium EmbryoidBody fromBlastocyst-derived-humanEmbryonicStemCells top-relative-expression-ranked 100
|
PCBC
|
7.681E-6
|
4.881E-4
|
3.479E-3
|
5.369E-3
|
3
|
100
|
12
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 200 k3
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 k-means-cluster#3 top-relative-expression-ranked 200
|
Gudmap Mouse MOE430.2
|
1.139E-5
|
6.634E-4
|
4.729E-3
|
7.961E-3
|
3
|
114
|
13
|
Facebase ST1 Univ 500
|
UniversalReference WholeMouseP1 top-relative-expression-ranked 500
|
FaceBase_ST1
|
1.683E-5
|
9.049E-4
|
6.450E-3
|
1.176E-2
|
4
|
427
|
14
|
PCBC ratio EB-blastocyst vs EB-cbCD34 500
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-derived-from CD34-iPSC top-relative-expression-ranked 500
|
PCBC
|
2.798E-5
|
1.397E-3
|
9.958E-3
|
1.956E-2
|
4
|
486
|
15
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 200
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 top-relative-expression-ranked 200
|
Gudmap Mouse MOE430.2
|
3.262E-5
|
1.520E-3
|
1.083E-2
|
2.280E-2
|
3
|
162
|
16
|
Facebase ST1 Univ 500 2
|
UniversalReference WholeMouseP1 top-relative-expression-ranked 500 2
|
FaceBase_ST1
|
7.926E-5
|
3.463E-3
|
2.468E-2
|
5.540E-2
|
2
|
33
|
17
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 500 k2
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 k-means-cluster#2 top-relative-expression-ranked 500
|
Gudmap Mouse MOE430.2
|
1.130E-4
|
4.644E-3
|
3.310E-2
|
7.896E-2
|
3
|
246
|
18
|
Sample Type by Project: Shred 1/TCGA-Liver/Hepatocellular Carcinoma/Hepatocellular Carcinoma/2/0
|
Sample Type by Project: Shred 1/TCGA-Liver/Hepatocellular Carcinoma/Hepatocellular Carcinoma/2/0
|
TCGA-Liver
|
1.549E-4
|
6.016E-3
|
4.288E-2
|
1.083E-1
|
2
|
46
|
19
|
gudmap developingLowerUrinaryTract e14.5 Genital tubercle 1000 k4
|
DevelopingLowerUrinaryTract e14.5 Genital tubercle emap-6706 k-means-cluster#4 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
1.759E-4
|
6.472E-3
|
4.613E-2
|
1.230E-1
|
2
|
49
|
20
|
PCBC ratio MESO-30 blastocyst vs MESO-30 fibroblast cfr-2X-p05
|
MESO-30 blastocyst vs MESO-30 fibroblast-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
3.912E-4
|
1.226E-2
|
8.742E-2
|
2.734E-1
|
3
|
375
|
21
|
PCBC ratio MESO-30 from-ESC vs MESO-30 from-OSKM - NLT cfr-2X-p05
|
Mesoderm Day 30-reprogram NA vs Mesoderm Day 30-reprogram OSKM - NLT-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
3.912E-4
|
1.226E-2
|
8.742E-2
|
2.734E-1
|
3
|
375
|
22
|
PCBC ratio MESO-30 from-ESC vs MESO-30 from-plasmid cfr-2X-p05
|
Mesoderm Day 30-method NA vs Mesoderm Day 30-method plasmid-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
3.912E-4
|
1.226E-2
|
8.742E-2
|
2.734E-1
|
3
|
375
|
23
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 1000 k4
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 k-means-cluster#4 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
4.035E-4
|
1.226E-2
|
8.742E-2
|
2.821E-1
|
3
|
379
|
24
|
ratio EB-blastocyst vs EB-cbCD34 2500 K3
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-derived-from CD34-iPSC top-relative-expression-ranked 2500 k-means-cluster#3
|
PCBC
|
4.454E-4
|
1.297E-2
|
9.247E-2
|
3.114E-1
|
3
|
392
|
25
|
gudmap developingLowerUrinaryTract e15.5 ureteral tissue 500
|
DevelopingLowerUrinaryTract e15.5 ureteral tissue emap-8234 top-relative-expression-ranked 500
|
Gudmap Mouse MOE430.2
|
4.936E-4
|
1.359E-2
|
9.684E-2
|
3.450E-1
|
3
|
406
|
26
|
Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Rectal Adenocarcinoma/5/0
|
Sample Type by Project: Shred 1/TCGA-Colorectal/Colorectal Adenocarcinoma/Rectal Adenocarcinoma/5/0
|
TCGA-Colorectal
|
5.054E-4
|
1.359E-2
|
9.684E-2
|
3.533E-1
|
2
|
83
|
27
|
gudmap kidney adult JuxtaGlom Ren1 k1 1000
|
kidney adult JuxtaGlom Ren1 k-means-cluster#1 top-relative-expression-ranked 1000
|
Gudmap Mouse MOE430.2
|
5.939E-4
|
1.538E-2
|
1.096E-1
|
4.151E-1
|
2
|
90
|
28
|
ratio EB-blastocyst vs EB-fibro 500 K3
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-fibro top-relative-expression-ranked 500 k-means-cluster#3
|
PCBC
|
7.036E-4
|
1.733E-2
|
1.235E-1
|
4.918E-1
|
2
|
98
|
29
|
PCBC EB 100
|
Progenitor-Cell-Biology-Consortium EmbryoidBody top-relative-expression-ranked 100
|
PCBC
|
7.325E-4
|
1.733E-2
|
1.235E-1
|
5.120E-1
|
2
|
100
|
30
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Tumour Wilms NK cell/Kidney Tumour Wilms NK4
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney NK cell/Kidney Tumour Wilms NK cell/Kidney Tumour Wilms NK4
|
Adult, Development, and Cancer types
|
8.244E-4
|
1.733E-2
|
1.235E-1
|
5.763E-1
|
1
|
2
|
31
|
Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Diffuse/5/4
|
Sample Type by Project: Shred 1/TCGA-Stomach/Stomach Adenocarcinoma/Stomach Adenocarcinoma - Diffuse/5/4
|
TCGA-Stomach
|
8.379E-4
|
1.733E-2
|
1.235E-1
|
5.857E-1
|
2
|
107
|
32
|
ratio SC-fibro vs SC-cbCD34 1000 K3
|
ratio StemCell-fibro vs StemCell-derived-from CD34-iPSC top-relative-expression-ranked 1000 k-means-cluster#3
|
PCBC
|
8.535E-4
|
1.733E-2
|
1.235E-1
|
5.966E-1
|
2
|
108
|
33
|
PCBC ratio SC-fibro vs SC-cbCD34 500
|
ratio StemCell-fibro vs StemCell-derived-from CD34-iPSC top-relative-expression-ranked 500
|
PCBC
|
8.537E-4
|
1.733E-2
|
1.235E-1
|
5.967E-1
|
3
|
490
|
34
|
PCBC EB blastocyst 500
|
Progenitor-Cell-Biology-Consortium EmbryoidBody fromBlastocyst-derived-humanEmbryonicStemCells top-relative-expression-ranked 500
|
PCBC
|
8.948E-4
|
1.733E-2
|
1.235E-1
|
6.255E-1
|
3
|
498
|
35
|
PCBC EB fibroblast 500
|
Progenitor-Cell-Biology-Consortium EmbryoidBody from inducedPluripotentialStemCells derived from from fibroblast top-relative-expression-ranked 500
|
PCBC
|
9.000E-4
|
1.733E-2
|
1.235E-1
|
6.291E-1
|
3
|
499
|
36
|
PCBC EB 500
|
Progenitor-Cell-Biology-Consortium EmbryoidBody top-relative-expression-ranked 500
|
PCBC
|
9.000E-4
|
1.733E-2
|
1.235E-1
|
6.291E-1
|
3
|
499
|
37
|
ratio SC-fibro vs SC-cbCD34 500 K2
|
ratio StemCell-fibro vs StemCell-derived-from CD34-iPSC top-relative-expression-ranked 500 k-means-cluster#2
|
PCBC
|
9.174E-4
|
1.733E-2
|
1.235E-1
|
6.413E-1
|
2
|
112
|
38
|
Facebase RNAseq ratio e9.5 MaxillaryArch vs Mandibular 1000 K5
|
FacebaseRNAseq ratio e9.5 MaxillaryArch vs Mandibular top-relative-expression-ranked 1000 k-means-cluster#5
|
FaceBase_RNAseq
|
1.196E-3
|
2.176E-2
|
1.551E-1
|
8.357E-1
|
2
|
128
|
39
|
Sample Type by Project: Shred 1/TCGA-Uterus/Uterine Carcinoma/Uterine Carcinosarcoma Heterologous Type/1/1
|
Sample Type by Project: Shred 1/TCGA-Uterus/Uterine Carcinoma/Uterine Carcinosarcoma Heterologous Type/1/1
|
TCGA-Uterus
|
1.214E-3
|
2.176E-2
|
1.551E-1
|
8.487E-1
|
2
|
129
|
40
|
ratio EB-blastocyst vs EB-fibro 1000 K3
|
ratio EmbryoidBody-blastocyst vs EmbryoidBody-fibro top-relative-expression-ranked 1000 k-means-cluster#3
|
PCBC
|
1.252E-3
|
2.187E-2
|
1.559E-1
|
8.749E-1
|
2
|
131
|
41
|
Sample Type by Project: Shred 1/TCGA-Kidney/Renal Cell Carcinoma/Kidney Clear Cell Renal Carcinoma/3/0
|
Sample Type by Project: Shred 1/TCGA-Kidney/Renal Cell Carcinoma/Kidney Clear Cell Renal Carcinoma/3/0
|
TCGA-Kidney
|
1.658E-3
|
2.826E-2
|
2.014E-1
|
1.000E0
|
2
|
151
|
42
|
Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/1/1
|
Sample Type by Project: Shred 1/TCGA-Cervix/Cervical Carcinoma/Keratinizing Cervical Squamous Cell Carcinoma/1/1
|
TCGA-Cervix
|
1.701E-3
|
2.831E-2
|
2.018E-1
|
1.000E0
|
2
|
153
|
43
|
Sample Type by Project: Shred 1/TCGA-Bile Duct/Cholangiocarcinoma/Hilar/Perihilar/5
|
Sample Type by Project: Shred 1/TCGA-Bile Duct/Cholangiocarcinoma/Hilar/Perihilar/5
|
TCGA-Bile Duct
|
1.974E-3
|
3.210E-2
|
2.288E-1
|
1.000E0
|
2
|
165
|
44
|
BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Endothelial Tip/Endothelial Tip/Endothelial Tip/Dcn//Nenf
|
BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Endothelial Tip/Endothelial Tip/Endothelial Tip/Dcn//Nenf
|
BrainMap
|
2.046E-3
|
3.250E-2
|
2.316E-1
|
1.000E0
|
2
|
168
|
45
|
Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Seminoma- NOS/7
|
Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Seminoma- NOS/7
|
TCGA-Testes
|
2.118E-3
|
3.290E-2
|
2.345E-1
|
1.000E0
|
2
|
171
|
46
|
Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Non-Seminoma- Yolk Sac Tumor/6
|
Sample Type by Project: Shred 1/TCGA-Testes/Testicular Germ Cell Tumor/Non-Seminoma- Yolk Sac Tumor/6
|
TCGA-Testes
|
2.217E-3
|
3.369E-2
|
2.401E-1
|
1.000E0
|
2
|
175
|
47
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Normal VHL RCC R U/Kidney Normal VHL RCC R12
|
Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney R U/Kidney Normal VHL RCC R U/Kidney Normal VHL RCC R12
|
Adult, Development, and Cancer types
|
2.343E-3
|
3.453E-2
|
2.461E-1
|
1.000E0
|
2
|
180
|
48
|
PCBC ratio MESO-15 from-ESC vs MESO-15 from-OSK-L-l-p53KD cfr-2X-p05
|
Mesoderm Day 15-reprogram NA vs Mesoderm Day 15-reprogram OSK-L-l-p53KD-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
2.421E-3
|
3.453E-2
|
2.461E-1
|
1.000E0
|
2
|
183
|
49
|
PCBC ratio MESO-15 from-ESC vs MESO-15 from-episomal cfr-2X-p05
|
Mesoderm Day 15-method NA vs Mesoderm Day 15-method episomal-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
2.421E-3
|
3.453E-2
|
2.461E-1
|
1.000E0
|
2
|
183
|
50
|
PCBC ratio iPSC method-OSK-l-p53KD vs ESC cfr-2X-p05
|
Pluripotent Stem Cells-reprogram OSK-l-p53KD vs Pluripotent Stem Cells-reprogram NA-Confounder removed-fold2.0 adjp0.05
|
PCBC_AltAnalyze
|
2.472E-3
|
3.455E-2
|
2.463E-1
|
1.000E0
|
1
|
6
|